Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism.
Sofia De TaddeoAikaterini AndreadiAlessandro MinasiIlenia D'IppolitoBarbara BorelliMarco MeloniMaria RomanoValeria RuotoloLaura CacciottiGiuseppe RizzoLodovico PatriziAlfonso BelliaDavide LauroPublished in: SAGE open medical case reports (2023)
Hyperandrogenism during menopause is often underestimated by clinicians and attributed to the natural aging process. Hyperandrogenism can be associated with some metabolic abnormalities linked together in a vicious circle by insulin resistance. We present the case of an elderly woman affected with type 2 diabetes and obesity who reported the occurrence of clinical hirsutism after physiological menopause at the age of 47 years. At presentation, physical examination and Ferriman-Gallwey score revealed a condition of moderate hirsutism, with markedly increased levels of plasma testosterone and delta-4-androstenedione, obesity (body mass index 31.9), and inadequate glycemic control (glycated hemoglobin 65 mmol/mol). The patient underwent a thorough differential diagnosis by a multidisciplinary team approach, including the various causes of hyperandrogenism during menopause. After choosing surgical option as the appropriate treatment, clinical resolution of hirsutism was observed alongside patient satisfaction and marked improvement of the glucometabolic profile.
Keyphrases
- insulin resistance
- polycystic ovary syndrome
- type diabetes
- glycemic control
- metabolic syndrome
- weight loss
- patient satisfaction
- high fat diet induced
- adipose tissue
- skeletal muscle
- case report
- physical activity
- high fat diet
- mental health
- blood glucose
- single cell
- risk assessment
- high intensity
- replacement therapy
- single molecule
- smoking cessation